TORONTO--(BUSINESS WIRE)--Today, Juno Pharmaceuticals Canada (“Juno”), a leader in the commercialization of specialty pharmaceuticals, announced the acquisition of Omega Laboratories (“Omega”), one of ...

Prevalence of Autism Spectrum Disorder (ASD) among children and youth aged 1 to 17 years, is about 2% (1 in 50) and is equivalent to about 150,000 cases in Canada in 2025 [1, 2]. Smith-Magenis ...

From established players to up-and-coming firms, Canada's pharmaceutical landscape is diverse and dynamic. Canadian drug companies are working to discover and develop major innovations amidst an ...

ADALAT® XL® (nifedipine extended-release tablets) first received market authorization in Canada in 1995 and is indicated for the management of chronic stable angina and the management of mild to ...

--DAYBUE is the first and only therapy approved in Canada for the treatment of Rett syndrome, a rare, neurodevelopmental disorder SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) ...

ARS Pharmaceuticals, Inc. has announced the filing for approval of neffy® (epinephrine nasal spray) 2 mg in Canada and the United Kingdom, where it will be marketed as EURneffy®. This follows neffy's ...

Entos® Pharmaceuticals (Entos), a clinical-stage genetic medicines company committed to using its Fusogenix™ PLV™ technology to develop cures, has announced a $62 million investment from the ...

– REDEMPLO is the first and only Health Canada-approved siRNA medicine to be studied in patients with genetically confirmed and clinically diagnosed FCS – People living with FCS have extremely high ...

A drug shortage report from Teva suggests the disruptions began in mid-March 2025. Early updates indicated supply could ...

Trump says sweeping 25% tariffs start Saturday on Mexico and Canada and threatens new tax on pharmaceuticals - Tariffs on Mexico and Canada will start Saturday, the White House confirmed ...

Kye Pharmaceuticals ("Kye"), a Canadian specialty pharmaceutical company based in Mississauga, Ontario, today announced that it has entered into a licensing and distribution agreement with Neurim ...

MISSISSAUGA, ON, Jan. 13, 2026 /PRNewswire/ - Kye Pharmaceuticals ("Kye"), a Canadian specialty pharmaceutical company based in Mississauga, Ontario, today announced that it has entered into a ...